Pei-jun Liu

Pei-jun Liu


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 February 2017 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
KQKai Qu
Kai Qu
ZWZhixin Wang
Zhixin Wang
HFHaining Fan
Haining Fan
JLJuan Li
Juan Li
JLJie Liu
Jie Liu
CLChang Liu
Chang Liu
DNA replication is a central procedure of cell proliferation, whereas aberrant DNA replication is indicated to be a driving force of oncogenesis. Minichromosome maintenance complex component 7 (MCM7) plays an essential role in initiating DNA replication. To investigate the potential oncogenic properties and prognostic value of MCM7 in hepatocellular carcinoma (HCC), we conducted immunohistochemistry staining of MCM7 in 153 HCC samples and found that MCM7 high expression level was associated with worse overall survival (OS) of HCC patients. Mechanistically, knockdown of MCM7 significantly inhibited cellular proliferation in vitro and HCC tumorigenicity in vivo. Cyclin D1 was proved to be regulated by MCM7–MAPK signaling pathway. Clinically, high expression of both MCM7 and cyclin D1 exhibited a relatively high sensitivity and specificity to predict worse outcome of HCC patients. Taken together, our results suggest that MCM7–cyclin D1 pathway may participate in cancer progression and serve as a biomarker for prognosis in HCC.

21 July 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CZCan Zhou
Can Zhou
LZLi Zhang
Li Zhang
HWHua Wang
Hua Wang
XMXiaoxia Ma
Xiaoxia Ma
BSBohui Shi
Bohui Shi
YRYU REN
YU REN
Compared with open oesophagectomy (OE), minimally invasive oesophagectomy (MIO) proves to have benefits in reducing the risk of pulmonary complications for patients with resectable oesophageal cancer. However, it is unknown whether MIO has superiority in reducing the occurrence of in-hospital mortality (IHM). The objective of this meta-analysis was to explore the effect of MIO vs. OE on the occurrence of in-hospital mortality (IHM). Sources such as Medline (through December 31, 2014), Embase (through December 31, 2014), Wiley Online Library (through December 31, 2014), and the Cochrane Library (through December 31, 2014) were searched. Data of randomized and non-randomized clinical trials related to MIO versus OE were included. Eligible studies were those that reported patients who underwent MIO procedure. The control group included patients undergoing conventional OE. Fixed or random -effects models were used to calculate summary odds ratios (ORs) or relative risks (RRs) for quantification of associations. Heterogeneity among studies was evaluated by using Cochran’s Q and I2 statistics. A total of 48 studies involving 14,311 cases of resectable oesophageal cancer were included in the meta-analysis. Compared to patients undergoing OE, patients undergoing MIO had statistically reduced occurrence of IHM (OR=0.69, 95%CI =0.55 -0.86). Patients undergoing MIO also had significantly reduced incidence of pulmonary complications (PCs) (RR=0.73, 95%CI = 0.63-0.86), pulmonary embolism (PE) (OR=0.71, 95%CI= 0.51-0.99) and arrhythmia (OR=0.79, 95%CI = 0.68-0.92). Non-significant reductions were observed among the included studies in the occurrence of anastomotic leak (AL) (OR=0.93, 95%CI =0.78-1.11), or Gastric Tip Necrosis (GTN) (OR=0.89, 95%CI =0.54-1.49). Most of the included studies were non-randomized case-control studies, with a diversity of study designs, demographics of participants and surgical intervention. Minimally invasive oesophagectomy (MIO) has superiority over open oesophagectomy (OE) in terms of the occurrence of in-hospital mortality (IHM) and should be the first-choice surgical procedure in esophageal surgery.

3 August 2020 in Cytoskeleton
Verified
Journal Article
Open access
PDF file
WSWei Sun
Wei Sun
BTBi‐Xia Tian
Bi‐Xia Tian
SWShu‐Hong Wang
Shu‐Hong Wang
PLPei-jun Liu
Pei-jun Liu
YWYao-chun Wang
Yao-chun Wang
Soluble N‐ethylmaleimide‐sensitive factor attachment protein receptor (SNARE) proteins are a large protein complex that is involved in the membrane fusion in vesicle trafficking, cell growth, cytokinesis, membrane repair, and synaptic transmission. As one of the SNARE proteins, SEC22B functions in membrane fusion of vesicle trafficking between the endoplasmic reticulum and the Golgi apparatus, antigen cross‐presentation, secretory autophagy, and other biological processes. However, apart from not being SNARE proteins, there is little knowledge known about its two homologs (SEC22A and SEC22C). SEC22B alterations have been reported in many human diseases, especially, many mutations of SEC22B in human cancers have been detected. In this review, we will introduce the specific functions of SEC22B, and summarize the researches about SEC22B in human cancers and other diseases. These findings have laid the foundation for further studies to clarify the exact mechanism of SEC22B in the pathological process and to seek new therapeutic targets and better treatment strategies.

1 November 2016 in European Journal of Cancer
Verified
Journal Article
Closed access
SWShu-Hong Wang
Shu-Hong Wang
QLQing-Yang Lu
Qing-Yang Lu
YGYa-Huan Guo
Ya-Huan Guo
YSYuan-Yuan Song
Yuan-Yuan Song
PLPei-jun Liu
Pei-jun Liu
YWYao-Chun Wang
Yao-Chun Wang

1 June 2014 in Journal of Surgical Research
Verified
Journal Article
Closed access
CZCan Zhou
Can Zhou
YRYu Ren
Yu Ren
JLJuan Li
Juan Li
XLXiao Li
Xiao Li
JHJianjun He
Jianjun He
PLPei-jun Liu
Pei-jun Liu

13 May 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
CZCan Zhou
Can Zhou
YRYu Ren
Yu Ren
JLJuan Li
Juan Li
KWKe Wang
Ke Wang
JHJianjun He
Jianjun He
PLPei-jun Liu
Pei-jun Liu
Rectal washout can prevent local recurrence after anterior resection of rectal cancer. Few studies have focused particularly on the association between irrigation fluids volume or agents and the risk of local recurrence after anterior resection of rectal cancer. To estimate the association between irrigation fluids types, volumes of rectal washout and risk of local recurrence after anterior resection for cancer. Relevant studies were identified by a search of Medline, Embase, Wiley Online Library, China National Knowledge Infrastructure, Cochrane Oral Health Group Specialized Register, Wanfang databases and Google Website from their inception until October 18,2013. Studies reporting the association between rectal washout types and volumes and risk of local recurrence after anterior resection for cancer were included. Eligible studies used rectal washout. Control groups were defined as no washout. Random-effects model were used to obtain summary estimates of RR and 95% CI, with Stata version 11 and RevMan 5.2.5 softwares used. The quality of report was appraised in reference to the MINORS item. Of the 919 rectal cancer patients in 8 included studies, a total of 61(6.64%) cases of local recurrence were reported, with a pooled RR 0.51 (95%CI = 0.28–0.92, P = 0.03). The RRs 0.37 and 0.39 in normal saline and washout volume (≥1500 ml normal saline) subgroup, respectively, indicated that rectal washout with normal saline, or ≥1500 ml in volume could significantly reduce local recurrence (LR) rate (95% CI = 0.17–0.79, P = 0.01; 95% CI = 0.18–0.87, P = 0.02) after anterior resection for cancer. The included studies were non-randomized observational studies, with diversity of study designs. Rectal washout with normal saline alone can reduce the risk of local recurrence in patients with resectable rectal cancer, and 1.5 liters rectal washout in volume is recommended.